Treatment Failure
10
1
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Pre-operative Characteristics for Prediction of Supraglottic Airway Failure Using Machine Learning (ERICA)
Incidence of the Treatment faIlure in Osteoporosis
The Factors Causing Treatment Failure in Children Receiving Oxygen Therapy With High-flow Nasal Cannula
DOAC ADRs Retrospective Study on Genetic Variations
RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia
Virologic Treatment Failure and Drug Resistance in HIV-infected Kenyan Children (RESPECT)
Safety and Immunogenicity Study of GX-70 in TB Patient
Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure
Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients